Safety of artemisinin and its derivatives a review of published and unpublished clinical trials

Medecine Tropicale

Volumn 58, Issue 3 SUPPL. 1, 1998, Pages 50-53

  Olliaro, P ^a  

^a NONE

Author keywords

Artemisinin derivatives; Clinical safety

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; ARTEMISININ DERIVATIVE; SESQUITERPENE;

BRADYCARDIA; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; FACTUAL DATABASE; GASTROINTESTINAL DISEASE; HUMAN; LONG QT SYNDROME; METHODOLOGY; NEUTROPENIA; REVIEW;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTIMALARIALS; ARTEMISININS; BRADYCARDIA; DATABASES, FACTUAL; DRUG MONITORING; GASTROINTESTINAL DISEASES; HUMANS; LONG QT SYNDROME; NEUTROPENIA; RESEARCH DESIGN; SESQUITERPENES;

EID: 0006899513     PISSN: 0025682X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. - BREWER T.G., GRATE S.J., PEGGINS J.O. et al. - Fatal neurotoxicity ofarteetherandartemether./tm. J. Tivp. Med.Hyg. 1994 ;51 :251-259.
2. - PRICE R.N., VAN VUGT M., LUXEMBURGER C. et al. - Treatment of acute falcipamm malaria with artemisinin derivatives : an analysis of adverses events from prospective studies in 3 645 patients. (Submitted for publication).